CBD pet products may face more FDA warnings, lawsuits

BY TIM WALL   The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol (CBD). That draft is currently at the White House for review. The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol…

5 Key Opportunities in the $29 Billion U.S. Pet Food Industry

Throughout much of 2020, the U.S. pet industry has been living up to its recession-resistant reputation, with pet food actually benefiting as a result of short-term pandemic-related buying and stockpiling. Given pet food’s essential nature, the future outlook is mostly positive as well, with a number of longer-term potential opportunities beginning to come into focus,…

Bioguard Corporation to officially announce the renaming of the Canine Blood Pathogen test, CDV/CAV/CIV test, and CPV/CCV/Giardia test to Vlabs 4X, Vlabs 3RX,and Vlabs 3DX.

Bioguard Corporation is proud and delighted to announce that we are changing our “Canine Blood Pathogen name to Vlabs 4X”, “CDV/CAV/CIV test to Vlabs 3RX”, CPV/CCV/Giardia to Vlabs 3DX. The name change is a result of an effort designed to be more compatible with our marketing strategy. In the spirit of renaming some of our…